At CENTOGENE, we established a free webinars series (live and on demand) on key developments in clinical diagnostics as well as giving insights into the latest research findings in the field of rare disease. Benefit from our renowned speakers and let us support you with daily routine implementation.
Find our CentoWebinar series 2017 here and stay updated by receiving our newsletter.
If you would like to have a topic covered that is not on the list, simply send us a short message.
Recorded webinars - CentoWebinars on demand
CentoWebinar - Clinical Exome Sequencing targets genes associated with all known clinical phenotypes to achieve high diagnostic accuracy
Watch our recorded webinar, “Clinical Exome Sequencing targets genes associated with all known clinical phenotypes to achieve high diagnostic accuracy” and find out how clinical utility meets patient affordability.
CentoWebinar - Specific biomarkers for lysosomal storage disorders: enabling diagnosis, prediction and therapy monitoring
Interested in the latest innovations in metabolic disease diagnostics and assessing the effects of therapy? Do you want to learn more about biochemical genetic testing at CENTOGENE? Join this webinar to learn more about novel biomarkers for lysosomal storage disorders (LSDs).
Looking for a one-stop-solution for your laboratory? Join this webinar to learn more about our CentoCloud® for diagnostic NGS panels, clinical bioinformatics & medical interpretation in the oncogenetic workflow.
Illumina and CENTOGENE joint webinar: Using NIPT to screen for the most common fetal chromosomal abnormalities
Everybody is talking about it: Non-invasive prenatal testing (NIPT) to screen for the most common fetal chromosomal abnormalities. With CentoNIPT® CENTOGENE now offers non-invasive prenatal testing that provides a fast and accurate screen. Get an introduction to NIPT and the difference with classic…
Tired of spending significant money and time only to end up with negative results? Join this webinar to discover a complete and unique test with increased diagnostic accuracy and significant time and cost savings.
A journey to the future - Whole genome sequencing for the diagnosis of heterogeneous genetic disorders
Last year CENTOGENE announced its new sequencing facility for rare hereditary disorders, which uses Illumina’s HiSeq X® sequencer. Some months after our journey started, our CSO Prof. Peter Bauer will explain CENTOGENE’s experience using this groundbreaking next generation sequencing (NGS)…
Solving the diagnostic riddle - Diagnosing heterogeneous genetic disorders with whole exome sequencing
Most of the disease-causing mutations that science has been able to identify so far are located within the exons. Whereas most genetic tests focus on a single gene or on a set number of predetermined genes, a whole exome sequencing test examines thousands of genes simultaneously.
Up to one third of all babies and children admitted to the intensive care unit (ICU) have a genetic disease. For many of them early identification can make a difference for their immediate and later health.
WGS identifies nearly all changes in a patient’s DNA by sequencing the entire coding and non-coding regions of the genome and provides detailed information on the thousands of genes involved in normal growth and development and all of the ‘silent’ genome regions simultaneously.
In this webinar you will learn the last insights in oncogenetics testing and how CENTOGENE gene panels can support you to assess the risk of a patient to develop an inherited cancer.